Anzeige
Mehr »
Login
Donnerstag, 11.08.2022 Börsentäglich über 12.000 News von 670 internationalen Medien
Jetzt zuschlagen? „Kursschnäppchen“ am Mittwoch: Heute letzte Chance vor nächster Rallye?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiMy body. My choice. Are we all talking about the same thing?
MiBeiGene announces positive phase 3 trial results for liver cancer treatment
MiSanofi halts recruitment for trials assessing MS treatment
MiMerck and Cerevance to research novel targets in Alzheimer's disease
MiMichael J Fox Foundation awards Koneksa second research grant
MiFDA approves Bot Image's AI software for the detection and diagnosis of prostate cancer
DiStrategic commitment
DiPfizer set to acquire Global Blood Therapeutics in deal worth $5.4bn
DiAstraZeneca and Daiichi Sankyo get FDA approval for breast cancer drug
DiNHS England launches hepatitis C screening scheme to reach 2030 elimination goal
DiBayer's Nubeqa receives FDA approval to treat metastatic prostate cancer
DiValneva and Pfizer initiate phase 3 Lyme disease vaccine study
MoBorn strategic - Why great strategists are both born and made
MoAbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
MoONS records a continued fall in UK COVID-19 infections
MoICR research shows how skin cancer cells invade new tissues
Mobluebird bio reveals plans to launch two gene therapies
MoUK government's 'science superpower' ambitions to fail without clear plan, Lords committee warns
FrAmgen acquires ChemoCentryx in $3.7bn cash deal
FrGilead Sciences set to acquire MiroBio in deal worth over $400m
FrNHS England to roll out continuous glucose monitors to all those with type 1 diabetes
FrSanofi and Innovent Biologics to develop oncology drugs for patients in China
FrWHO launches funding appeal for greater Horn of Africa prompted by food crisis
04.08.The patient voice - the value of patient-reported outcomes in HTA
04.08.AstraZeneca and MSD's breast cancer drug Lynparza receives EC approval